Payoneer Q3 2026 Earnings: B2B Volume Accelerates as Operating Profit Declines
Payoneer Global Inc. reported Q3 2026 revenue of $276.9 million, up 2% year-over-year, while GAAP diluted EPS remained unchanged at $0.04. Although total payment volume rose 13%—driven by strong B2B and Checkout expansion—revenue growth was constrained by lower interest income and a 12-basis-point decline in the take rate. Operating income fell 31% due to higher R&D and amortization expenses, while net income rose 6% on favorable financial income. Key risks include ongoing take-rate compression, interest-rate sensitivity, rising operating costs, marketplace weakness, and regulatory execution regarding the pending Nuvei transaction targeted for mid-2027.
Payoneer Global Inc. (NASDAQ: PAYO) reported Q3 2026 revenue of $276.9 million, up 2% from $270.9 million a year earlier, while GAAP diluted EPS was unchanged at $0.04. Total volume rose 13% to $25.3 billion as B2B volume increased 59%, but lower interest income and a 12-basis-point decline in take rate limited revenue growth. GAAP operating income fell to $25.1 million, while net income increased 6% with help from a favorable swing in financial income.
Core Financial Results
Revenue excluding interest income increased 5% to $222.2 million, but interest income fell 8% to $54.7 million. This limited total revenue growth to 2% despite the double-digit increase in payment volume.
Transaction costs decreased slightly and represented a smaller percentage of revenue. However, higher research and development, depreciation and amortization, and other operating expenses contributed to lower operating income and adjusted EBITDA.
| Metric | Q3 2026 | Q3 2025 | Year-Over-Year Change |
|---|---|---|---|
| Revenue | $276.9 million | $270.9 million | +2% |
| Revenue excluding interest income | $222.2 million | $211.4 million | +5% |
| Transaction costs as a percentage of revenue | 15.0% | 15.7% | -70 bps |
| GAAP operating income | $25.1 million | $36.3 million | Approximately -31% |
| GAAP net income | $14.9 million | $14.1 million | +6% |
| GAAP diluted EPS | $0.04 | $0.04 | Unchanged |
| Adjusted EBITDA | $68.3 million | $71.3 million | -4% |
| Adjusted EBITDA excluding interest income | $13.6 million | $11.7 million | +16% |
Payoneer’s adjusted EBITDA measures are non-GAAP. Based on reported figures, GAAP operating margin declined to approximately 9.1% from 13.4%.
Business and Channel Performance
B2B was the main volume growth driver, supported by acceleration across major regions and momentum with larger customers, particularly in China and EMEA. Checkout also expanded rapidly, while the marketplace channel was comparatively weak.
| Channel | Q3 2026 Volume | Volume Growth | Q3 2026 Revenue | Revenue Growth |
|---|---|---|---|---|
| Marketplace SMBs | $12.6 billion | +1% | $115 million | -5% |
| B2B SMBs | $5.0 billion | +59% | $70 million | +13% |
| Checkout | $330 million | +48% | $14 million | +60% |
| Enterprise payouts | $7.4 billion | +14% | Not provided | Not provided |
Average revenue per user increased 18% to $555. ARPU excluding interest income rose 21%, marking the ninth consecutive quarter with growth above 20%. Meanwhile, the overall take rate declined to 109 basis points from 121 basis points, and the SMB customer take rate decreased to 111 basis points from 121 basis points.
Geographically, Greater China revenue rose to $95.2 million from $91.2 million, and Asia-Pacific revenue increased to $60.8 million from $57.2 million. EMEA was nearly unchanged at $68.6 million, while Latin America declined to $24.6 million from $28.0 million.
Faster Volume Growth Did Not Translate Proportionally into Revenue
The gap between 13% volume growth and 2% revenue growth is central to understanding the quarter. B2B volume increased 59%, but B2B SMB revenue rose 13%; marketplace volume grew 1%, while associated revenue declined 5%. The lower take rate captures this weaker revenue generated per dollar of payment volume.
At the same time, rising ARPU indicates that Payoneer generated more revenue per active customer. The two trends are not contradictory: ARPU measures revenue per active customer, while take rate measures revenue relative to transaction volume. Payoneer’s larger-customer strategy supported customer-level monetization, but it did not prevent the company-wide take rate from declining.
Interest income created an additional headwind. Customer funds increased 6% year over year to $7.5 billion, but lower interest rates caused interest income to fall 8%, partially offsetting growth in the underlying payments business.
Profitability, Cash Flow, and Balance Sheet
Total operating expenses increased to $251.8 million from $234.5 million, outpacing revenue growth. Research and development expense rose to $50.0 million from $39.9 million, while depreciation and amortization increased to $21.4 million from $16.1 million. These increases more than offset the modest decline in transaction costs and contributed to the reduction in operating income.
Net income nevertheless increased because net financial income was $6.2 million, compared with a $5.8 million financial expense in the prior-year quarter. This approximately $12.0 million positive swing supported GAAP earnings despite weaker operating profit.
Cash flow figures were reported for the first nine months of 2026 rather than for Q3 alone. Nine-month operating cash flow increased to $180.4 million from $171.9 million. Payoneer used $92.5 million for share repurchases during the period, while cash and cash equivalents declined to $362.6 million at September 30 from $415.5 million at the end of 2025.
Management’s View
CEO John Caplan said the continued acceleration in B2B, higher ARPU excluding interest income, and a rising revenue contribution from larger customers supported Payoneer’s upmarket strategy. The company also obtained payment licenses in Canada and Israel, expanding its regulatory infrastructure.
Payoneer continues to target a mid-2027 closing of its pending transaction with Nuvei. Shareholders approved the merger proposal on September 14, 2026, but necessary regulatory approvals remain outstanding. Q3 M&A-related expenses totaled $3.1 million, including $2.7 million of third-party costs related to the pending acquisition by Nuvei.
Recent Insider Transactions
The six-month insider summary classified eight transactions totaling 719,086 shares as purchases and one transaction involving 25,000 shares as a sale, producing net purchases of 694,086 shares. However, the detailed list includes multiple zero-price stock awards, so the purchase total should not be interpreted as eight open-market purchases.
The only recent sale in the supplied transaction data was made by Payoneer’s chief financial officer.
| Date | Insider | Transaction | Shares | Price | Reported Value |
|---|---|---|---|---|---|
| June 15, 2026 | Beatrice Ordonez, CFO | Direct sale | 25,000 | $7.01 | $175,250 |
The latest listed transaction was an indirect stock gift by director Amir Goldman on June 22, 2026, but the supplied data did not provide the number of shares.
Risks Investors Should Monitor
- Lower payment monetization: The take rate declined by 12 basis points, meaning continued volume growth may not produce comparable revenue growth if this trend persists.
- Interest-rate sensitivity: Interest income fell 8% even though customer funds increased 6%, showing that lower rates can offset balance growth.
- Operating expense pressure: Higher R&D and depreciation and amortization expenses contributed to an approximately 31% decline in operating income and a lower operating margin.
- Marketplace weakness: Marketplace SMB revenue declined 5% despite a 1% increase in associated volume, creating a drag on the broader SMB business.
- Nuvei transaction execution: The targeted mid-2027 closing still depends on regulatory approvals, while transaction-related costs are already affecting reported expenses.
Summary
Payoneer’s Q3 2026 results showed clear operating momentum in B2B, Checkout, total volume, and ARPU, but that growth did not translate proportionally into revenue or operating profit. Lower take rates, declining interest income, and higher operating costs were the main constraints. The next areas to monitor are whether B2B growth can improve overall monetization, whether expense growth moderates, and whether the Nuvei transaction receives the approvals needed for its targeted mid-2027 closing.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles









Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.